Education
About Us
Working with TipRanks
Follow Us
ExpreS2ion Biotech Holding AB (DE:5JD0)
:5JD0
5JD0 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.54 - €8.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€4.71M
Enterprise Value-€33.90M
Total Cash (Recent Filing)kr81.54M
Total Debt (Recent Filing)kr360.00K
Price to Earnings (P/E)―
Beta1.17
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.66
Shares Outstanding2,658,346
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)28.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
5JD0 FAQ
What was ExpreS2ion Biotech Holding AB’s price range in the past 12 months?
ExpreS2ion Biotech Holding AB lowest stock price was €1.54 and its highest was €8.00 in the past 12 months.
What is ExpreS2ion Biotech Holding AB’s market cap?
ExpreS2ion Biotech Holding AB’s market cap is €4.71M.
When is ExpreS2ion Biotech Holding AB’s upcoming earnings report date?
ExpreS2ion Biotech Holding AB’s upcoming earnings report date is May 15, 2025 which is in 28 days.
How were ExpreS2ion Biotech Holding AB’s earnings last quarter?
ExpreS2ion Biotech Holding AB released its earnings results on Feb 06, 2025. The company reported -€0.634 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.634.
Is ExpreS2ion Biotech Holding AB overvalued?
According to Wall Street analysts ExpreS2ion Biotech Holding AB’s price is currently Overvalued.
Does ExpreS2ion Biotech Holding AB pay dividends?
ExpreS2ion Biotech Holding AB does not currently pay dividends.
What is ExpreS2ion Biotech Holding AB’s EPS estimate?
ExpreS2ion Biotech Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ExpreS2ion Biotech Holding AB have?
ExpreS2ion Biotech Holding AB has 2,658,346 shares outstanding.
What happened to ExpreS2ion Biotech Holding AB’s price movement after its last earnings report?
ExpreS2ion Biotech Holding AB reported an EPS of -€0.634 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.6%.
Which hedge fund is a major shareholder of ExpreS2ion Biotech Holding AB?
Currently, no hedge funds are holding shares in DE:5JD0
---
Company Description
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 300 proteins and 40 virus-like particles (VLPs) in collaboration with research institutions and companies.
---
Technical Analysis
OncoZenge AB
―
Modus Therapeutics Holding AB
―
Spago Nanomedical AB
―
CombiGene AB
―
Sprint Bioscience AB
―
---